Abstract
Background and purpose
Because myxoid liposarcomas are more radiosensitive than other soft tissue sarcomas, there have been several reports of 50 Gy preoperative radiation therapy combined with surgery, but the wound complication rate is reportedly high. We have performed preoperative irradiation at a reduced dose of 40 Gy and definitive radiation therapy for unresectable cases. This study aimed to report the tumor reduction rate and oncological results with a reduced dose of preoperative irradiation and the outcome of definitive irradiation for unresectable cases.
Materials and methods
Forty-one patients with myxoid liposarcoma treated in our institution between 2002 and 2021 were included. We examined the tumor volume shrinkage rate with preoperative radiation, compared complications and oncological outcomes between preoperative radiation and surgery-only cases, and investigated the prognosis and tumor shrinkage of definitive radiation cases.
Results
The total dose irradiated was 40 Gy except in two cases. The mean tumor volume reduction rate was 52.0%. A decreased dose of preoperative radiation did not worsen clinical outcomes with fewer complications. The total dose of definitive radiation was approximately 60 Gy. The mean tumor volume reduction rate was 55.0%. The tumor shrinkage maintenance rate was 100% in a median follow-up period of 50.5 months.
Conclusion
Preoperative radiation therapy for myxoid liposarcoma near vital organs is a good approach because even with a reduced dose of 40 Gy, significant tumor reduction and excellent results were achieved. Definitive radiation therapy is the recommended treatment for older patients with serious comorbidities or inoperable patients.
Similar content being viewed by others
References
Weiss SW, Goldblum JR, Enzinger FM (2007) Enzinger and Weiss’s soft tissue tumors, 5th edn. Mosby, St. Louis
Chung PW, Deheshi BM, Ferguson PC et al (2009) Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas. Cancer 115:3254–3261. https://doi.org/10.1002/cncr.24375
de Vreeze RSA, de Jong D, Haas RL et al (2008) Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. Int J Radiat Oncol Biol Phys 72:1480–1487. https://doi.org/10.1016/j.ijrobp.2008.03.008
Salduz A, Alpan B, Valiyev N et al (2017) Neoadjuvant radiotherapy for myxoid liposarcomas: oncologic outcomes and histopathologic correlations. Acta Orthop Traumatol Turc 51:355–361. https://doi.org/10.1016/j.aott.2017.03.009
Chowdhry V, Goldberg S, DeLaney TF et al (2018) Myxoid liposarcoma: treatment outcomes from chemotherapy and radiation therapy. Sarcoma 2018:8029157. https://doi.org/10.1155/2018/8029157
O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235–2241. https://doi.org/10.1016/S0140-6736(02)09292-9
Moreau LC, Turcotte R, Ferguson P et al (2012) Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases. Ann Surg Oncol 19:1081–1088. https://doi.org/10.1245/s10434-011-2127-z
Guadagnolo BA, Zagars GK, Ballo MT et al (2008) Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 70:760–765. https://doi.org/10.1016/j.ijrobp.2007.07.2337
Engström K, Bergh P, Cederlund CG et al (2007) Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncol 46:838–845. https://doi.org/10.1080/02841860601080415
Kataoka K, Tanaka K, Mizusawa J et al (2014) Bone and soft tissue tumor study group of the japan clinical oncology group. a randomized phase ii/iii trial of perioperative chemotherapy with adriamycin plus ifosfamide versus gemcitabine plus docetaxel for high-grade soft tissue sarcoma: japan clinical oncology group study JCOG1306. Jpn J Clin Oncol 44:765–769. https://doi.org/10.1093/jjco/hyu080
Fletcher CDM, Unni KK, Mertens F (2002) World health organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. IARC Press, Lyon pp 341–67
Lim MC, Tan CH, Cai J et al (2014) CT volumetry of the liver: where does it stand in clinical practice? Clin Radiol 69:887–895. https://doi.org/10.1016/j.crad.2013.12.021
Kachare SD, Brinkley J, Vohra NA et al (2015) Radiotherapy associated with improved survival for high-grade sarcoma of the extremity. J Surg Oncol 112:338–343. https://doi.org/10.1002/jso.23989
Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305–315. https://doi.org/10.1097/00000658-198209000-00009
Delaney TF, Kepka L, Goldberg SI et al (2007) Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 67:1460–1469. https://doi.org/10.1016/j.ijrobp.2006.11.035
Dürr H, Bakhshai Y, Tunn PU (2015) Chirurgische therapie von Weichteilsarkomen der Extremit¨aten. Onkologe 20:1075–1087. https://doi.org/10.1007/s00761-014-2710-6
Davis AM, O’Sullivan B, Turcotte R et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48–53. https://doi.org/10.1016/j.radonc.2004.12.020
Lansu J, Bovée JVMG, Braam P et al (2021) Dose reduction of preoperative radiotherapy in myxoid liposarcoma: a nonrandomized controlled trial. JAMA Oncol 7:e205865. https://doi.org/10.1001/jamaoncol.2020.5865
Wortman JR, Tirumani SH, Tirumani H et al (2016) Neoadjuvant radiation in primary extremity liposarcoma: correlation of MRI features with histopathology. Eur Radiol 26:1226–1234. https://doi.org/10.1007/s00330-015-3953-3
Acknowledgements
None.
Funding
No financial support was received for this study.
Author information
Authors and Affiliations
Contributions
Conceptualization, A.S., H.K.; methodology, A.S., H.K., Y.H.; formal analysis, A.S.; investigation, A.S., Y.H.; data curation, A.S., Y.H.; writing—original draft preparation, A.S.; writing—review and editing, H.K., T.O., H.M., J.W., M.M., H.H., H.A., M.T.; supervision, H.K.; project administration, A.S. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This study was approved by the Shizuoka Cancer Center Hospital (approval number: J2021-173-2021-1-2), and all investigations were conducted in accordance with the ethical principles of the Shizuoka Cancer Center Hospital.
Consent for publication
Patients and their families provided written consent for the publication of patient data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shimatani, A., Katagiri, H., Murata, H. et al. Significance of radiation therapy in the myxoid round-cell liposarcoma treatment regimen. Int J Clin Oncol (2024). https://doi.org/10.1007/s10147-024-02534-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10147-024-02534-y